Get Your Personalized Supplement StackSupplement Stack Quiz

Amlaki

Q: Is Amlaki effective for cholesterol?

Yes, meta-analyses of clinical trials show Amlaki significantly reduces LDL (bad cholesterol), total cholesterol, and triglycerides, while increasing HDL (good cholesterol).

Q: Can it help with blood sugar?

Yes, Amlaki has been shown to significantly lower fasting blood glucose levels in adults with elevated blood sugar, suggesting benefits for glycemic control.

Q: Is it safe long-term?

Short to medium-term use (up to 6 months) of Amlaki appears safe and well-tolerated. However, data on safety for continuous use beyond 6 months are currently limited.

Q: When is the best time to take Amlaki?

There is no strict best time to take Amlaki. Consistent daily dosing, typically as directed by the supplement, is generally recommended for optimal benefits.

Q: Are there any common side effects?

Side effects from Amlaki are uncommon and generally mild when taken at recommended doses. No significant adverse events have been reported in major clinical trials.

Also known as: Amlaki, Indian Gooseberry, Amla, Phyllanthus emblica, Emblica officinalis

Overview

Amlaki, scientifically known as Emblica officinalis (or Phyllanthus emblica), is the fruit of a tree widely utilized in traditional medicine, particularly within the Ayurvedic system. It is highly valued for its potent antioxidant, anti-inflammatory, and metabolic health-supporting properties. Commonly available as a powder, extract, or juice, Amlaki has been the subject of increasing scientific scrutiny. Recent research, including randomized controlled trials (RCTs) and systematic reviews, has focused on its efficacy in modulating lipid profiles, glucose metabolism, and inflammatory markers. While the quality of evidence is generally moderate, with several well-conducted studies, further research with longer intervention durations and larger sample sizes would enhance the understanding of its full therapeutic potential.

Benefits

Amlaki offers several evidence-based benefits, primarily for metabolic and cardiovascular health. A systematic review and meta-analysis of five RCTs demonstrated that Amlaki supplementation significantly improves lipid profiles by reducing low-density lipoprotein cholesterol (LDL-c), total cholesterol (TC), and triglycerides (TG), while simultaneously increasing high-density lipoprotein cholesterol (HDL-c) (all p < 0.001). This suggests strong evidence for its role in dyslipidemia management. The same meta-analysis also reported significant reductions in fasting blood glucose (FBG) (p < 0.001), indicating its potential for glycemic control, particularly in adults with metabolic risk factors. Furthermore, Amlaki has been shown to significantly reduce C-reactive protein (CRP), a key marker of systemic inflammation (p = 0.002). Another systematic review corroborated these findings, confirming its beneficial effects on various physiological risk factors for cardiovascular disease. These benefits are most pronounced in middle-aged adults (40–58 years) with an average BMI of approximately 25.5, with effects typically observed within 3 to 12 weeks of consistent supplementation.

How it works

Amlaki's therapeutic effects are attributed to its rich composition of bioactive compounds, including high levels of vitamin C, polyphenols, and tannins. These compounds exert potent antioxidant and anti-inflammatory actions. It is believed to modulate lipid metabolism by inhibiting lipid peroxidation and enhancing the clearance of lipids, leading to reductions in LDL-c and triglycerides. Its glucose-lowering effect may stem from improved insulin sensitivity and the antioxidant protection it provides to pancreatic beta cells, which are crucial for insulin production. The anti-inflammatory properties are likely mediated by the downregulation of pro-inflammatory cytokines and C-reactive protein. While bioavailability can vary by preparation, standardized extracts, particularly those rich in polyphenols, are commonly used in research to ensure consistent efficacy.

Side effects

Amlaki is generally considered safe for oral consumption within recommended dosages. Clinical studies indicate that it is well-tolerated, with no significant adverse events reported in the randomized controlled trials included in meta-analyses. Mild and rare side effects may occur, but they are not commonly documented. Specific safety data suggests it can be taken at doses up to 1,000 mg daily for up to 6 months, 1,500 mg daily for up to 2 months, and 2,000 mg daily for up to 1 month. Topical application is also deemed safe at concentrations up to 3% for up to 60 days. Currently, there are no major drug interactions or contraindications that have been definitively established in high-quality research, making it a relatively safe supplement for most individuals. However, long-term safety data beyond 6 months of continuous use are limited.

Dosage

Effective dosages of Amlaki, as observed in clinical trials, typically range from 500 mg to 1,000 mg daily of a standardized extract. The duration of intervention in these studies varied from 3 to 12 weeks, with some evidence suggesting that beneficial effects on lipid profiles and glucose regulation may become apparent within 4 to 8 weeks of consistent use. While there is no strict timing for administration, consistent daily dosing, often as per the supplement manufacturer's instructions, is recommended. It's important to note that the optimal dosage may depend on the specific extract standardization and an individual's unique metabolic status. While short to medium-term use (up to 6 months) appears safe, longer-term safety data beyond this period are not yet well-established.

FAQs

Is Amlaki effective for cholesterol?

Yes, meta-analyses of clinical trials show Amlaki significantly reduces LDL (bad cholesterol), total cholesterol, and triglycerides, while increasing HDL (good cholesterol).

Can it help with blood sugar?

Yes, Amlaki has been shown to significantly lower fasting blood glucose levels in adults with elevated blood sugar, suggesting benefits for glycemic control.

Is it safe long-term?

Short to medium-term use (up to 6 months) of Amlaki appears safe and well-tolerated. However, data on safety for continuous use beyond 6 months are currently limited.

When is the best time to take Amlaki?

There is no strict best time to take Amlaki. Consistent daily dosing, typically as directed by the supplement, is generally recommended for optimal benefits.

Are there any common side effects?

Side effects from Amlaki are uncommon and generally mild when taken at recommended doses. No significant adverse events have been reported in major clinical trials.

Research Sources

https://pubmed.ncbi.nlm.nih.gov/36934568/ – This systematic review and meta-analysis of five randomized controlled trials investigated the effects of Amlaki on lipid and glucose metabolism. It found significant reductions in LDL-c, total cholesterol, triglycerides, and fasting blood glucose, along with an increase in HDL-c, supporting Amlaki's role in improving metabolic markers.
https://pmc.ncbi.nlm.nih.gov/articles/PMC10251691/ – This systematic review and meta-analysis focused on the impact of Amlaki on cardiovascular risk factors. It confirmed beneficial effects on lipid and glucose parameters, suggesting that Amlaki can improve the overall cardiovascular risk profile in adults.
https://www.webmd.com/vitamins/ai/ingredientmono-784/indian-gooseberry – This WebMD summary provides an overview of the safety and efficacy of Indian Gooseberry (Amlaki) based on clinical evidence. It indicates that Amlaki is generally safe at recommended doses and can be effective for conditions like dyslipidemia and heartburn, though long-term safety data are still limited.